| • | | a Private Placement Warrants Purchase Agreement, dated October 27, 2021, between the Company and the Sponsor, pursuant to which the Sponsor purchased 7,000,000 private placement warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share, subject to adjustment, at a price of $1.50 per warrant (the “Private Placement Warrants” and, together with the Public Warrants, the “Warrants”), attached here as Exhibit 10.4. |
The above descriptions are qualified in their entirety by reference to the full text of the applicable agreement, each of which is incorporated by reference herein and filed herewith as Exhibits 1.1, 4.1, 10.1, 10.2, 10.3 and 10.4, respectively.
Item 3.02. Unregistered Sales of Equity Securities.
Simultaneously with the consummation of the IPO and the issuance and sale of the Units, the Company consummated the private sale of 7,800,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, generating total proceeds of $11,700,000. The Private Placement Warrants, which were purchased by the Sponsor, are identical to the Public Warrants, except that (i) the Private Placement Warrants will not be redeemable by the Company, (ii) the Private Placement Warrants (and Class A Ordinary Shares issuable upon exercise of the Private Placement Warrants) may be subject to certain transfer restrictions contained in the Letter Agreement, (iii) the Private Placement Warrants may be exercised by holders on a cashless basis, and (iv) the holders of the Private Placement Warrants (including the Class A Ordinary Shares issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. The Private Placement Warrants have been issued pursuant to, and are governed by the Warrant Agreement.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 27, 2021, in connection with the IPO, Baroness Helena Morrissey (the “New Director”) was appointed to the board of directors of the Company (the “Board”). Effective October 27, 2021, (i) each of Baroness Helena Morrissey, Mei Lim and Amy Nauiokas were appointed to the audit committee, (ii) each of Pamela Thomas Graham, Baroness Helena Morrissey and Janice Savin Williams were appointed to the compensation committee and (iii) each of Pamela Thomas Graham, Baroness Helena Morrissey and Janice Savin Williams were appointed to the nominating and corporate governance committee.
Following the appointment of the New Director, the Board is comprised of three classes. The term of office of the first class of directors, consisting of Janice Savin Williams, will expire at the Company’s first annual general meeting. The term of office of the second class of directors, consisting of Pamela Thomas Graham and Baroness Helena Morrissey, will expire at the second annual general meeting. The term of office of the third class of directors, consisting of Mei Lim and Amy Nauiokas, will expire at the third annual general meeting.
The Company will enter into indemnity agreements with the New Director and reimburse the New Director for reasonable out-of-pocket expenses incurred in connection with fulfilling her role as director. Other than the foregoing, the New Director is not party to any arrangement or understanding with any person pursuant to which she was appointed as director, nor is she party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.